Vitable Health

vitablehealth.com →

-57%

est. 2Y upside i

HealthcareSeries A

Affordable care via ICHRA and primary care with visits, meds, labs…

Rank

#293

Sector

HealthTech

Est. Liquidity

~4Y

Data Quality

Data: Medium

Vitable Health presents a strong upside opportunity for a job seeker, with an estimated 131.75% expected upside over a two-year horizon, though this is based on an assumed current valuation of $200M.

Last updated: March 10, 2026

Bull (23%)+400%

Vitable Health successfully scales its DPC + ICHRA model, expanding to over 40 states and capturing significant market share among small and mid-sized employers, especially post-Liferaft acquisition. Revenue reaches $100M+ by 2028, justifying a $1.0B valuation at 10x revenue multiple, driven by strong customer acquisition and retention.

Base (50%)+120%

Vitable Health continues to execute on its current strategy, growing revenue to $55M by 2028. It maintains its niche but faces ongoing competition, leading to a valuation of $440M, representing a moderate increase from its current assumed $200M valuation.

Bear (27%)-75%

Increased competition from larger players entering the small business DPC/ICHRA space or adverse regulatory changes hinder Vitable's growth. Revenue growth slows significantly, or customer churn increases, leading to a down round or acquisition at a reduced valuation of $50M, severely impacting common stock value.

Est. time to liquidity~3.5 years

Preference Stack Risk

moderate

Investors hold $25M in liquidation preferences, representing 12.5% of the assumed current $200M valuation.

Dilution Risk

high

As a Series A company, Vitable Health will likely undergo multiple additional funding rounds to fuel its ambitious expansion plans, leading to further dilution of common stock.

Secondary Liquidity

none

No active secondary market or tender offers are expected for a Series A company within a 2-year horizon.

View all 9 open roles at Vitable Health →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Vitable Health's data — designed to show you've done your homework.

  • 1

    “How is Vitable Health planning to maintain its competitive moat and differentiation if dominant incumbents like Teladoc or traditional insurers decide to more aggressively target the small business and hourly worker segment with similar DPC + ICHRA offerings?”

  • 2

    “With current revenue around $29M and ambitious plans to expand to over 40 states, what are the key operational and sales milestones for the next 12-24 months, and how do you measure success in terms of customer acquisition cost (CAC) and retention for your target employers?”

  • 3

    “Given the Series A funding and the typical timeline for venture-backed companies, what is the company's long-term vision for a liquidity event, and what are the key value-creation milestones you believe will be most impactful for employee equity over the next 3-5 years?”

Community

Valuation Sentiment

Our model estimates -57% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.